93 related articles for article (PubMed ID: 9708944)
1. Telomerase activity as an indicator of potentially malignant adrenal tumors.
Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; Tsuda F
Cancer; 1998 Aug; 83(4):772-6. PubMed ID: 9708944
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in benign and malignant adrenal tumors.
Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
[TBL] [Abstract][Full Text] [Related]
3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in neuroendocrine tumors.
Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in soft-tissue and bone sarcomas.
Aogi K; Woodman A; Urquidi V; Mangham DC; Tarin D; Goodison S
Clin Cancer Res; 2000 Dec; 6(12):4776-81. PubMed ID: 11156234
[TBL] [Abstract][Full Text] [Related]
10. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
11. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Koyanagi K; Ozawa S; Ando N; Mukai M; Kitagawa Y; Ueda M; Kitajima M
Cancer; 2000 Apr; 88(7):1524-9. PubMed ID: 10738208
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.
Aogi K; Kitahara K; Buley I; Backdahl M; Tahara H; Sugino T; Tarin D; Goodison S
Clin Cancer Res; 1998 Aug; 4(8):1965-70. PubMed ID: 9717826
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
15. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
17. Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Kammori M; Nakamura K; Kanauchi H; Obara T; Kawahara M; Mimura Y; Kaminishi M; Takubo K
World J Surg; 2002 Sep; 26(9):1083-7. PubMed ID: 12209236
[TBL] [Abstract][Full Text] [Related]
18. Expression of telomerase (hTERT) in aldosterone-producing adrenocortical tumors.
Sticchi D; Fassina A; Ganzaroli C; Pasqualetto C; Pessina AC; Nussdorfer GG; Rossi GP
Int J Mol Med; 2006 Mar; 17(3):469-74. PubMed ID: 16465394
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs.
Biller BJ; Kitchell BE; Cadile CD
Am J Vet Res; 1998 Dec; 59(12):1526-9. PubMed ID: 9858400
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
